Počet záznamů: 1
PERISCOPE: road towards effective control of pertussis
- 1.
SYSNO ASEP 0504929 Druh ASEP J - Článek v odborném periodiku Zařazení RIV J - Článek v odborném periodiku Poddruh J Článek ve WOS Název PERISCOPE: road towards effective control of pertussis Tvůrce(i) Diavatopoulos, D.A. (NL)
Šebo, Peter (MBU-M) RID, ORCID
Večerek, Branislav (MBU-M) RID, ORCIDCelkový počet autorů 34 Zdroj.dok. Lancet Infectious Diseases. - : Elsevier - ISSN 1473-3099
Roč. 19, č. 5 (2019), E179-E186Poč.str. 8 s. Jazyk dok. eng - angličtina Země vyd. GB - Velká Británie Klíč. slova b-cell responses ; bordetella-pertussis ; immune-responses Vědní obor RIV EE - Mikrobiologie, virologie Obor OECD Microbiology Způsob publikování Omezený přístup Institucionální podpora MBU-M - RVO:61388971 UT WOS 000466036400006 EID SCOPUS 85065499882 DOI 10.1016/S1473-3099(18)30646-7 Anotace The resurgence and changing epidemiology of pertussis in high-income countries, the high infant mortality caused by pertussis in low-income countries, and the increasing morbidity in all age groups worldwide call for a concerted effort to both improve the current vaccines and develop new vaccines and vaccination strategies against pertussis. In this Personal View, we identify several key obstacles on the path to developing a durable solution for global control of pertussis. To systematically address these obstacles, the PERtussIS Correlates Of Protection Europe ( PERISCOPE) Consortium was established in March, 2016. The objectives of this consortium are to increase scientific understanding of immunity to pertussis in humans induced by vaccines and infections, to identify biomarkers of protective immunity, and to generate technologies and infrastructure for the future development of improved pertussis vaccines. By working towards the accelerated licensure and implementation of novel, well tolerated, and effective pertussis vaccines, we hope to strengthen and stimulate further collaboration and transparency between the key stakeholders, including the public, the scientific community, public health institutes, regulatory authorities, and vaccine manufacturers. Pracoviště Mikrobiologický ústav Kontakt Eliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231 Rok sběru 2020 Elektronická adresa https://www.sciencedirect.com/science/article/pii/S1473309918306467?via%3Dihub
Počet záznamů: 1